Nuveen’s Corbus Pharmaceuticals CRBP Stock Holding History

Nuveen’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45,689	Closed	-$243K	–	3296
2025 Q1	$243K	Buy	45,689 +16,751	+58%	+$148K	﹤0.01%	3079
2024 Q4	$341K	Sell	28,938 -101,232	-78%	-$1.7M	﹤0.01%	3099
2024 Q3	$2.69M	Buy	130,170 +102,272	+367%	+$5.23M	﹤0.01%	2280
2024 Q2	$1.26M	Buy	+27,898	New	+$1.17M	﹤0.01%	2614
2021 Q2	–	Sell	-8,437	Closed	-$2.34M	–	3400
2021 Q1	$2.34M	Buy	8,437 +270	+3%	+$17.7K	﹤0.01%	2543
2020 Q4	$2.27M	Hold	8,167	–	–	﹤0.01%	2444
2020 Q3	$2.27M	Sell	8,167 -17,371	-68%	-$3.15M	﹤0.01%	2315
2020 Q2	$6.43M	Buy	25,538 +17,122	+203%	+$3.46M	﹤0.01%	1757
2020 Q1	$1.32M	Buy	8,416 +1,612	+24%	+$273K	﹤0.01%	2389
2019 Q4	$1.11M	Hold	6,804	–	–	﹤0.01%	2648
2019 Q3	$994K	Sell	6,804 -390	-5%	-$67.9K	﹤0.01%	2707
2019 Q2	$1.5M	Buy	+7,194	New	+$1.54M	﹤0.01%	2568

Other funds holding CRBP

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Exome Asset Management New York $170M AUM 208.51% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return